Home topics news Image provided by Australian Museum Eureka Prize News Tech News 3D bioprinting tech wins Australian Museum Eureka Prize 2021 Heidi Heck October 11, 2021 On Friday, the Australian Museum Eureka Prize 2021 announced that the RASTRUM printer developed by Inventia Life Science had won first place in its Eureka Prize for Innovative Use of Technology . Inventia’s 3D bio-printer RASTRUM uses inkjet printer technology to print lifelike human cells. The revolutionary technology will advance researchers’ ability to understand how new drugs and treatments will react with real living cells. The technology is currently being used to print cancer cells so researchers can test and optimise chemotherapy and other cancer treatments. Inventia Inventia Life Science is an Australian biotech startup company located in Sydney. Founded in 2013, its aim is “The development, manufacture and sale of equipment and reagents for advanced medical research assays by means of 3D bioprinting,” with an emphasis on low-cost, standardised technology to transform medical research. A company representative spoke about the funding the company has received to bring its 3D bioprinting tech to life. “Inventia was initially funded by its founder, Dr Julio Ribeiro, from 2011 to 2017, when it received its Seed round of $1.6m in early 2017 led by Blackbird Ventures, and an oversubscribed Series A round of $10m in late 2018 that combined many of Australia’s leading VC funds – Blackbird, Skip Capital, Main Sequence and AirTree.” In the journey, Inventia Life Science received both federal & NSW government grants